Prevalence of Metabolic Syndrome in Type 2 Diabetes Mellitus Using NCEP-ATPIII, IDF and WHO Definition and Its Agreement in Gwalior Chambal Region of Central India

Abstract

The aim of study was to determine the prevalence of metabolic syndrome (MetS) in people with type 2 diabetes mellitus (T2DM). National Cholesterol Education Program (NCEP) ATPIII Criteria, International Diabetes Federation and the World Health Organization (WHO) definitions were used in quantifying the metabolic syndrome and also the concordance between these three criteria’s used for identifying metabolic syndrome.Methods:This cross-sectional study involved 700 type 2 diabetic subjects from the urban areas of Gwalior Chambal region (Central India). Subjects in the age group of 28-87 yrs were included in the study. Type I diabetics, pregnant ladies and those with chronic viral and bacterial infections and serious metabolic disorders were excluded from the study. Fasting blood glucose, Blood lipids (T-cholesterol, triglyceride, HDL-cholesterol) were assessed and anthropometry blood pressure were measured from all the subjects.Results:The Prevalence of metabolic syndrome was found to be 45.8%, 57.7% and 28% following NCEP-ATPIII Criteria, IDF and WHO definitions, respectively. Using all the three definitions the prevalence was higher in women in all age groups. ATP III and IDF criteria showed good agreement (κ 0.68) compared to ATP III with WHO (κ 0.54) and IDF with WHO (κ 0.34) criteria. Highest prevalence was observed following IDF definition.Conclusions:A good agreement was observed between ATPIII and IDF criteria. Maximum prevalence of Metabolic syndrome was recorded when IDF criteria was followed. NCEP-ATPIII criteria for the diagnosis of MetS and this criterion reflected equal importance to the every variable and showed a good agreement between the different criteria used.

Excess Metabolic Syndrome Risks Among Women Health Workers Compared With Men

“…Also pending the availability of more specific data, the Europid waist circumference cutoff, which was implored in this study, has been advocated for the sub‐Sahara African population . The prevalence of MetS in the general population ranges between 17% and 25% . In our study, the frequency of MetS compared with that of a previous study by Ijeh and colleagues in Nigeria, who reported a prevalence rate of 30.7%, was at variant with the study by Ulasi and colleagues, who reported a lower prevalence of 15.9% in a Nigerian community.…”

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

“…Recent evidence has described the prevalence of metabolic syndrome in Canada, 54 Latin America, 55 India, 56,57 Bangladesh, 58 Iran, 59 Nigeria, 60 South Africa, 61 and Vietnam, 62 as well as many other countries. On the basis of data from NIPPON DATA, the age-adjusted prevalence of metabolic syndrome in a Japanese population was 19.3%.…”

Alanine Aminotransferase and Risk of the Metabolic Syndrome: A Linear Dose-Response Relationship

“…It was not possible to achieve a comparable outcome definition of MetS across all studies, as different criteria (NCEP-ATP III or IDF) were used and two studies substituted BMI for waist circumference in their definition of abdominal obesity. However, the NCEP-ATP III and IDF definitions have been found to show good agreement in the diagnosis of MetS [42], [43]. Additionally, BMI has been suggested as equally effective as waist circumference for predicting the development of metabolic disorders[44], [45] and has been adopted in previous studies of the MetS [1], [46].…”